Articles From: MediciNova Announces New NIDA Grant for MN-166 (ibudilast) in Opioid Dependence to Medifast Selects GKV As Agency Of Record


LA JOLLA, Calif., Sept.
Sign-up for MediciNova Announces New NIDA Grant for MN-166 (ibudilast) in Opioid Dependence investment picks
LA JOLLA, Calif., Sept.
Sign-up for MediciNova Provides Update on Phase 2b Trial of MN-166 (ibudilast) in Progressive MS investment picks
Medidata (NASDAQ:MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences, and Pharmaceutical Product Development, LLC (PPD), a global contract research organization (CRO), today announced they are expanding their partnership to provide the life science industry with a more comprehensive approach to risk-based monitoring (RBM)—aimed at conducting drug development more intelligently, more quickly and more cost-effectively.
Sign-up for Medidata and PPD Partner to Offer New Approach to Risk-Based Monitoring investment picks
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the results of a data-driven analysis conducted in collaboration with TransCelerate BioPharma Inc. ("TransCelerate"), which assesses the value of source document verification (SDV) in a risk-based approach to clinical trial site monitoring.
Sign-up for Medidata and TransCelerate BioPharma Inc. Announce Findings of Joint Research Initiative on Clinical Trial Site Monitoring Methods investment picks
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the availability of its enriched solution for risk-based monitoring (RBM) of clinical trial sites.
Sign-up for Medidata Announces Availability of Patient Profiles Offering investment picks
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Michael L.
Sign-up for Medidata Appoints Mike Capone Chief Operating Officer investment picks
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the completion of a method development project conducted in partnership with GlaxoSmithKline plc (GSK) to evaluate the impact of unifying mobile health (mHealth) devices with cloud-based technologies in a clinical trial setting.
Sign-up for Medidata Collaborates with GlaxoSmithKline on Mobile Health Initiative to Test Novel Technology for Clinical Trial Optimization investment picks
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced its financial results for the third quarter of 2014 and revised its 2014 guidance.
Sign-up for Medidata Reports Record Third Quarter 2014 Revenues investment picks
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its third quarter 2014 financial results before the open of the market on Tuesday, October 28, 2014.
Sign-up for Medidata Schedules Third Quarter Earnings Conference Call for October 28, 2014 investment picks
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals , an oncology-focused biotechnology company.
Sign-up for Medidata Selected by ASLAN Pharmaceuticals as Enterprise-Wide Technology Platform for Enhancing Clinical Development investment picks
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology for clinical research in life sciences, today announced that Mundipharma Research Limited (Mundipharma) has adopted Medidata’s cloud-based software platform to streamline and accelerate its drug development activities.
Sign-up for Medidata Teams up with Mundipharma Research to Move Clinical Research to the Cloud investment picks
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will host a financial analyst day on Monday, December 8, 2014 in New York City.
Sign-up for Medidata to Host Financial Analyst Day in New York City on December 8 investment picks
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Bryan Spielman, Medidata’s executive vice president of strategy and corporate development, and Takeru Yamamoto, Medidata’s managing director of the Asia-Pacific region, will join U.S. Secretary of Commerce Penny Pritzker on her first trade mission to Asia since taking office in June 2013.
Sign-up for Medidata to Participate in U.S. Trade Mission to Japan and South Korea, Supporting Stronger Economic Ties in Healthcare and Energy Sectors investment picks
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the latest release of the Medidata Clinical Cloud™ and the immediate availability of new capabilities and enhancements that broaden the company’s platform of advanced technologies and data analytics.
Sign-up for Medidata Unveils Latest Release of Medidata Clinical Cloud™ investment picks
2014/9/24
http://media.marketwire.com/attachments/201305/158360_120584_twitter_pr_small.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1146949&ProfileId=051205&sourceType=1 EFFINGHAM COUNTY, GA --
Sign-up for Medient Studios, Inc. Announces Choate Construction Company Appointed as Construction Manager investment picks
Leading Weight Management Company Expands Product Offering OWINGS MILLS, Md.
Sign-up for Medifast Adds Holiday Inspired Gingerbread Soft Bake to Product Line investment picks
Leading Weight Management Program Celebrates Success Stories OWINGS MILLS, Md.
Sign-up for Medifast Announces Winners of National "Happy Afters" Contest investment picks
Mona Ameli will lead company's direct selling division OWINGS MILLS, Md.
Sign-up for Medifast Appoints President, Take Shape For Life investment picks
Kenneth Kopp will lead company's direct response division OWINGS MILLS, Md.
Sign-up for Medifast Appoints Vice President, Medifast Direct investment picks
Company to Close 34 Corporate Centers, Transition 17 Locations to Franchise Owners OWINGS MILLS, Md.
Sign-up for Medifast Implements Next Phase Of Weight Control Center Strategy investment picks
OWINGS MILLS, Md.
Sign-up for Medifast Launches New Digital Dashboards to Help Customers Track Success investment picks
Leading Weight-Management Company Expands Product Line OWINGS MILLS, Md.
Sign-up for Medifast Launches New Energy Drops & Flavor Infusers™ investment picks
Leading Weight-Management Company Tackles Long-Term Wellness with Thrive by Medifast™ and Optimal Health by Take Shape For Life™ Launches OWINGS MILLS, Md.
Sign-up for Medifast Launches New Healthy Living Program and Product Lines investment picks
Meg Sheetz Recognized for Leadership at Medifast & Contributions to the Baltimore Community OWINGS MILLS, Md.
Sign-up for Medifast President and COO Named to The Baltimore Sun's 50 Women to Watch List investment picks
Multi-Faceted Partnership includes Marketing Strategy and Creative Campaign Development BALTIMORE , Oct.
Sign-up for Medifast Selects GKV As Agency Of Record investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: MediciNova Announces New NIDA Grant for MN-166 (ibudilast) in Opioid Dependence to Medifast Selects GKV As Agency Of Record
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent